These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 2416769)

  • 81. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
    van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
    J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Unusual antagonistic actions of mixtures of vasoactive intestinal peptide, thyroid-stimulating antibodies, and cholera toxin on adenosine 3',5'-monophosphate accumulation in normal human thyroid cell cultures.
    Brandi ML; Rotella CM; Kohn LD; Toccafondi R
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1199-205. PubMed ID: 2871039
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Thyrotropin (TSH) receptor modulation by specific TSH receptor antibodies in Graves' disease.
    de Bruin TW; Bussemaker JK; Heidema J; Hermans J; van der Heide D
    J Clin Endocrinol Metab; 1988 Oct; 67(4):676-81. PubMed ID: 2901428
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination.
    Rao PV; Watson PF; Weetman AP; Carayanniotis G; Banga JP
    Endocrinology; 2003 Jan; 144(1):260-6. PubMed ID: 12488353
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease.
    Kim WB; Chung HK; Park YJ; Park DJ; Tahara K; Kohn LD; Cho BY
    Thyroid; 2000 Jul; 10(7):579-86. PubMed ID: 10958310
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter.
    van der Gaag RD; Drexhage HA; Wiersinga WM; Brown RS; Docter R; Bottazzo GF; Doniach D
    J Clin Endocrinol Metab; 1985 May; 60(5):972-9. PubMed ID: 2858493
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.
    Muehlberg T; Gilbert JA; Rao PV; McGregor AM; Banga JP
    Endocrinology; 2004 Apr; 145(4):1539-45. PubMed ID: 14764633
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
    Zakarija M; Jin S; McKenzie JM
    J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease.
    Davies TF; Platzer M
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
    Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies.
    Ilicki A; Gamstedt A; Karlsson FA
    J Clin Endocrinol Metab; 1992 May; 74(5):1090-4. PubMed ID: 1349025
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Adipocyte-TSH-receptor-related antibodies in Graves' disease detected by immunoprecipitation.
    Konishi J; Iida Y; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):219-26. PubMed ID: 6127208
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 96. TSH-receptor expression and human thyroid disease: relation to clinical, endocrine, and molecular thyroid parameters.
    Schuppert F; Deiters S; Rambusch E; Sierralta W; Dralle H; von zur Muhlen A
    Thyroid; 1996 Dec; 6(6):575-87. PubMed ID: 9001192
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
    de Bruin TW; van der Heide D
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways.
    Gilbert JA; Gianoukakis AG; Salehi S; Moorhead J; Rao PV; Khan MZ; McGregor AM; Smith TJ; Banga JP
    J Immunol; 2006 Apr; 176(8):5084-92. PubMed ID: 16585606
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Inhibition of metabolic activity of polymorphonuclear granulocytes by thyroid stimulating antibodies.
    Balázs C; Bokk A; Kiss E
    J Endocrinol Invest; 1992 Jun; 15(6):465-9. PubMed ID: 1357025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.